ArticleClinical epigenetics2018

CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway.

Janina Graule et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.